PARKINSON'S DISEASE NEWS

17th May 2009 - News release

NEW METHOD OF DIAGNOSING PARKINSON'S DISEASE

Transgenomic and Power3 Medical have announced the introduction of a new blood test for Parkinson's Disease called NuroPro® PD. The NuroPro PD test can help clinicians distinguish patients with Parkinson’s diseases from those that don't have Parkinson's Disease, and those people with other neurological disorders. The tests are a panel of blood serum protein biomarkers that are evaluated to predict the probability that somebody has Parkinson's Disease.

The results showed that NuroPro PD was able to discriminate between Parkinson’s Disease patients and age-matched control subjects with a sensitivity of 93% and specificity of 96%. Samples from Parkinson’s Disease patients were correctly identified with 100% sensitivity when tested. The aim is to market NuroPro PD in the near future. For more information go to the Press release. As many as 25% of people with Parkinson's Disease are wrongly diagnosed. So a method of diagnosing Parkinson's Disease that was far more accurate than symptom questionnaires, and much cheaper than the relatively expensive scanning methods, would be a major development. For current methods of diagnosis, go to Diagnosis of Parkinson's Disease. For more current news go to Parkinson's Disease News.

E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News,  please double click on  E-MAIL NOTIFICATION, or e-mail [email protected].  No form of identity is required.  E-mail addresses are not used for any other purpose.

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports.